Literature DB >> 3451227

Clostridium difficile colitis following treatment with metronidazole and vancomycin.

P J Bingley1, G M Harding.   

Abstract

A 25 year old woman developed Clostridium difficile colitis following a course of vancomycin and metronidazole prescribed for pelvic inflammatory disease. The condition resolved after treatment with vancomycin given alone. Colitis following this combination of antibiotics has not been described previously.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3451227      PMCID： PMC2428710          DOI： 10.1136/pgmj.63.745.993

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Relapse of pseudomembranous colitis after vancomycin therapy.

Authors:  R G Finch; H J Thomas; M J Lewis; R C Slack; R H George
Journal:  Lancet       Date:  1979-11-17       Impact factor: 79.321

2.  Antibiotic-associated colitis--the continuing saga.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-13

3.  Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; F J Tedesco; S Shull; B Lowe; T Chang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

4.  Colitis associated with metronidazole therapy.

Authors:  R Saginur; C R Hawley; J G Bartlett
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

5.  Diagnosis of pseudomembranous colitis.

Authors:  A Kappas; N Shinagawa; Y Arabi; H Thompson; D Burdon; F Dimock; R H George; J Alexander-Williams; M R Keighley
Journal:  Br Med J       Date:  1978-03-18
  5 in total
  8 in total

Review 1.  Taming the Beast: Interplay between Gut Small Molecules and Enteric Pathogens.

Authors:  Aman Kumar; Melissa Ellermann; Vanessa Sperandio
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 2.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

Review 3.  [Individualized treatment strategies for Clostridium difficile infections].

Authors:  P Solbach; P Dersch; O Bachmann
Journal:  Internist (Berl)       Date:  2017-07       Impact factor: 0.743

Review 4.  Clostridium difficile-associated disease: changing epidemiology and implications for management.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

6.  Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.

Authors:  Preetika Sinh; Terrence A Barrett; Laura Yun
Journal:  Gastroenterol Res Pract       Date:  2011-09-12       Impact factor: 2.260

7.  Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine.

Authors:  Abdallah Damin Abukhalil; Liana AbuKhdeir; Malak Hamed; Ni'meh Al Shami; Hani A Naseef; Banan M Aiesh; Ali Sabateen
Journal:  Infect Drug Resist       Date:  2021-11-09       Impact factor: 4.003

8.  Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination.

Authors:  Lise Tornvig Erikstrup; Mie Aarup; Rikke Hagemann-Madsen; Frederik Dagnaes-Hansen; Brian Kristensen; Katharina Elisabeth Pribil Olsen; Kurt Fuursted
Journal:  BMJ Open Gastroenterol       Date:  2015-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.